Cultivating brand advantage for CDMOs

Tackling the perennial challenge of innovation in the pharmaceutical industry

picture of Joel Biswas, Coley Porter Bell

Breaking News

Thermo Fisher acquires Irish API manufacturing site from GSK

Thermo Fisher will pay $100 million to acquire the site but continue to produce APIs for GSK in the upcoming years

Lonza to manufacture oral somatostatin analogue MYCAPSSA drug candidate in the UK

The Swiss CDMO has signed an advance commercial supply agreement with Chiasma, the US-based biopharma company

Fujifilm Diosynth announces further UK cell culture expansion plans

The construction of the new BioCampus is estimated to cost £12.6m ($16.3m)

The Manufacturing Chemist outsourcing roundtable: part I

Discussing the upcoming and ongoing trends in the contract pharmaceutical sector, Dr Kevin Robinson recently caught up ...

Legacy Pharmaceuticals announces long-term lyophilisation strategy

A lyophilisation suite is in the works, with closed RABS filling line technology, 2 to 3 freeze-driers up to 30 sqm ...

FDA allows ADMA intravenous globulin back on the market

This is not the first release of this drug to the US, after initial approval in 2012, it was removed due to ...

The Manufacturing Chemist outsourcing roundtable: part II

Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by ...

Recipharm introduces end-to-end inhalation platform

Platform offers service from early stage development through commercial manufacturing

Precigen opens cell and gene therapy facility in Maryland

The Intrexon subsidiary facility will scale production to fit clinical trial needs

CDMO market trends and dynamics

The rise of the embedded model

Broad stripes, bright stars and a thriving pharmaceutical industry: part I

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” ...

IIoT: shaping pharma’s future

Government regulation has presented new hurdles to the pharmaceutical and medical device industries within the last ...

Novartis signs manufacturing memorandum in Saudi Arabia

Sudair Pharmaceuticals will work with the Swiss company on oncology drugs, which are in high demand as the country’s ...

Alector chooses Lonza platform for manufacturing scale-up

The companies have extended collaboration beyond the early phases to include using the Ibex Solutions platform for ...